Clinical Trial Update: Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by PATH evaluating strategies to reduce malaria transmission in Kanel, Ranérou and Linguère districts has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: PATH | Conditions: Malaria | Phase 4 | Status: COMPLETED